ACHV ACHIEVE LIFE SCIENCE INC NASDAQ trendline. If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
On 8/7/2020 Brokerage LADENBURG THALM/SH SH Reiterated ACHV Rating to BUY and set the target price to $100.00, now the cost of one share is 9.84usd. You can find the asset on trading212, the most downloaded trading app in the U.K. With a market cap of $15.45 million and a worldwide working product, it`s hard to say ACHV can go lower than that. The only concern is...
Exlposion emminent? Looking at the outstanding shares, float increasing volume and good fundamentals this stock could explode...
Wyckoff Schematic #2 seems to be in action. This has followed my plan so far, I just need it to pull back a bit more, or produce an entry signal for a Buy and Hold. Portfolio building is the key.
On July 31th : Achieve Life Sciences receives U.S. patent for its novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders. Aimed at regaining compliance with Nasdaq's $1 minimum bid price listing requirement, Achieve Life Sciences has executed a 1:20 reverse split of its common stock. Achieve Life Sciences is scheduled...
This could break, bounce down inside and break up... or sometimes the high just cant be broken and but in on the low when i dips hard. Just have to see. Set alerts.
Hi, today we are going to talk about Achieve Life Sciences and its current landscape. Achieve Life Sciences has been surrounded by increasing speculation over its shares after a couple of days ago had unveiled an update on the cytisinicline (a drug to aid smoking cessation ) clinical development program, as the FDA had agreed with the overall Phase 3 study...
********KEEP ON THE WATCHLIST FOR BREAKOUT, IMPROVED TRIAL RESULTS RELEASED, WITH CONFERENCE CALL TO FOLLOW LATER IN THE DAY******* Achieve Life Sciences, Inc. ACHV, clinical-stage pharmaceutical company focused on nicotine addiction, today announced positive results from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The outcome of the...
In hindsight, the stock appears to be forming a downward trend all together aggregating moment to a strong bullish movement. Appear to be diligent as various announcements and press releases can also further regress the stock's overall valuation. Not investment advice, simply for personal and educational purposes only.
Buy signal detected. Both MACD and Momentum BUY signal detected
nice round bottom strong EOW closing good news Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option PR NewswireJune 19, 2018
Up 69% this morning, I am in at 2.7, huge profit ahead. TP1: 2.5 TP 2: 2.25 TP 3: 2.10